Opinion · 31 Jan 2025
Conference abstractPublished 2016
Gut microbiota modulates cisplatin mediated systemic toxicity
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Anticancer chemotherapy has achieved a significant milestone in increasing the number of cancer survivors over past decades, while leaving behind the survivors with various toxic side effects, which are nephrotoxicity, ototoxicity and intestinal damage. Challenges remain to reduce systemic toxicity as well as retaining the anticancer therapy. Gut microbiota modulates cancer chemotherapy, however little is known about the role of gut microbiota in modulating systemic toxicity. We hypothesized that gut microbiota regulates systemic toxicity. Four groups (n=10/group) of 8 weeks old C57B/6 mice were treated with cisplatin, cisplatin+antibiotics cocktails (ABX), ABX only and untreated. ABX cocktail contained primaxin, vancomycin and neomycin, which depletes broad spectrum gut microbiota. This experiment was validated using C57B/6 germ free mice (contains no microorganisms). We performed anti-p-Ã?³-H2AX and anti-ATM based DNA-double stranded break (stains foci in the nuclei) based toxicity assay in kidney and gut (small bowel). H&E and 4 color immunostaining (anti-p-Ã?³-H2AX, anti-ATM, Actin and DAPI) were done. DNA-DSBs were evaluated using Zeiss 780 confocal and quantified by 3-D reconstruction using IMARIS. There were reductions in Ã?³-H2AX+ DAPI+ (DNA damaged) cell populations compared to only cisplatin treated mice, indicated protection in the kidney. Both nuclear foci counts as well as the pathological scores indicated gut microbiota associated modulation in the glomeruli of kidney and in the villi of small bowel. Our data leads to a possibility to develop microbiota based therapy which might be utilized to reduce chemotherapy associated systemic toxicity and for better management of chemotherapy.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 30 Dec 2024
The Role of Gut Microbiota in Modulating Inflammation and Cancer Progression
Research article · 12 Dec 2024
Microbiome and Cancer: Examining the Influence of Gut Microbiota on Immunotherapy Efficacy and Toxicity
Perspective · 29 Apr 2024
The Interplay between Gut Microbiota and Immune System: Implications for Health and Disease
Mini review · 18 Mar 2023
Therapeutic Approaches that Target the Gut Microbiota to Modulate the Immune System
More from this journal
The newest in Oncology & Cancer Case Reports.
Article · 21 Jul 2026
Endocrine sequencing in ESR1-mutant HR+/HER2â?? metastatic breast cancer: a two-case series
Article · 23 Jan 2026
Marked Response after One Cycle of Pembrolizumab Monotherapy for Non-small Cell Lung Cancer: A Case Report and Brief Review of the Literature
Article · 15 Oct 2025
High-Grade Pulmonary Fetal Adenocarcinoma: A Case Report
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalOncology & Cancer Case Reports
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Soumen Roy”
- BylineArticles whose byline prints “Rodrigo Das Neves”
- BylineArticles whose byline prints “Carolyne Smith”
- BylineArticles whose byline prints “Bathai Edwards”
- BylineArticles whose byline prints “Amiran Dzutsev”
- BylineArticles whose byline prints “Loretta Smith”
- BylineArticles whose byline prints “Simone Difilippantonio”
- BylineArticles whose byline prints “Lake Ross”
